The difference between Talking-to and talking-with

During a recent meeting with a representative of a pharmaceutical multinational company, we analyzed the results of a survey. It centered on the channels and the modality of approach which physicians consider the most interesting. The survey core question appeared to be: “what is your preferred channel to receive pharmaceutical detailing?” The results [...]

By | 20 Luglio, 2017|0 Comments

Pharmaceutical Multichannel Marketing doesn’t exists

It appeared clearer than ever during a conversation with an Innovation and Multichannel group at Pfizer. We were analyzing the data and looking for the reasons of the success of an initiative that involved Multichannel and use of the remote informator- after partnering in this activity for more than an year. Was it [...]

By | 20 Luglio, 2017|0 Comments